Synchronous bilateral breast cancer with heterogeneous hormone receptor status: a case report
The expression of estrogen, progesterone, and HER2 receptors in breast cancer cells helps guide treatment and predict outcomes. When the status of these receptors is heterogeneous, it makes treatment planning more complex. We present the case of a 72-year-old woman with bilateral breast cancer with heterogenous receptor status and subsequent challenges in management.
Authors
- Badal Karki (ORCID: https://orcid.org/0009-0000-7473-0039)
- Prajjwol Luitel (ORCID: https://orcid.org/0000-0001-6725-5575)
- Suzita Hirachan
- Sujan Paudel (ORCID: https://orcid.org/0009-0007-7132-0588)
- Suraj Pariyar
- Asim Shrestha
Institutions
- Tribhuvan University Teaching Hospital (NP)
Publication Details
- Journal
- Journal of Surgical Case Reports
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1093/jscr/rjae786
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00